Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Reiner

Showing results (341-350 of 354) with videos related to

Pageof 36
Sort By:
Journal of Clinical Pathology|February 25, 2006
The value of cytokeratin immunohistochemistry in the evaluation of axillary sentinel lymph nodes in patients with lobular breast carcinomaG Cserni, S Bianchi, V Vezzosi, et al.
Journal of Surgical Oncology|April 1, 1994
Adoptive cellular therapy of human breast and colorectal tumor targets using ex vivo activated memory T lymphocytes with potentiation by cis-diamminedichloroplatinum(II)J E Gold, I J Bleiweiss, A B Goldfarb, et al.
Health Technology Assessment (Winchester, England)|October 7, 2010
Open-label, randomised, parallel-group, multicentre study to evaluate the safety, tolerability and immunogenicity of an AS03(B)/oil-in-water emulsion-adjuvanted (AS03(B)) split-virion versus non-adjuvanted whole-virion H1N1 influenza vaccine in UK children 6 months to 12 years of ageCs Waddington, N Andrews, K Hoschler, et al.
Cancer|August 9, 2017
Double-blind, randomized phase 3 trial of low-dose 13-cis retinoic acid in the prevention of second primaries in head and neck cancer: Long-term follow-up of a trial of the Eastern Cooperative Oncology Group-ACRIN Cancer Research Group (C0590)Aarti K Bhatia, Ju-Whei Lee, Harlan A Pinto, et al.
Nutrition & Diabetes|August 28, 2013
Generalization of adiposity genetic loci to US Hispanic womenM Graff, L Fernández-Rhodes, S Liu, et al.
BMJ (Clinical Research Ed.)|May 29, 2010
Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre studyClaire S Waddington, W T Walker, C Oeser, et al.
Breast Cancer Research and Treatment|November 15, 2014
Pathological non-response to chemotherapy in a neoadjuvant setting of breast cancer: an inter-institutional studyD Balmativola, C Marchiò, M Maule, et al.
European Journal of Cancer (Oxford, England : 1990)|September 7, 2000
Causes of inconsistency in diagnosing and classifying intraductal proliferations of the breast. European Commission Working Group on Breast Screening PathologyC W Elston, J P Sloane, I Amendoeira, et al.
Virchows Archiv : an International Journal of Pathology|January 29, 2016
Consistency in recognizing microinvasion in breast carcinomas is improved by immunohistochemistry for myoepithelial markersG Cserni, C A Wells, H Kaya, et al.
British Journal of Cancer|November 21, 2013
Relative survival of patients with non-malignant central nervous system tumours: a descriptive study by the Austrian Brain Tumour RegistryA Woehrer, M Hackl, T Waldhör, et al.
Pageof 36

Showing results (341-350 of 354) with videos related to

Sort By:
Pageof 36
Journal of Clinical Pathology|February 25, 2006
The value of cytokeratin immunohistochemistry in the evaluation of axillary sentinel lymph nodes in patients with lobular breast carcinomaG Cserni, S Bianchi, V Vezzosi, et al.
Journal of Surgical Oncology|April 1, 1994
Adoptive cellular therapy of human breast and colorectal tumor targets using ex vivo activated memory T lymphocytes with potentiation by cis-diamminedichloroplatinum(II)J E Gold, I J Bleiweiss, A B Goldfarb, et al.
Health Technology Assessment (Winchester, England)|October 7, 2010
Open-label, randomised, parallel-group, multicentre study to evaluate the safety, tolerability and immunogenicity of an AS03(B)/oil-in-water emulsion-adjuvanted (AS03(B)) split-virion versus non-adjuvanted whole-virion H1N1 influenza vaccine in UK children 6 months to 12 years of ageCs Waddington, N Andrews, K Hoschler, et al.
Cancer|August 9, 2017
Double-blind, randomized phase 3 trial of low-dose 13-cis retinoic acid in the prevention of second primaries in head and neck cancer: Long-term follow-up of a trial of the Eastern Cooperative Oncology Group-ACRIN Cancer Research Group (C0590)Aarti K Bhatia, Ju-Whei Lee, Harlan A Pinto, et al.
Nutrition & Diabetes|August 28, 2013
Generalization of adiposity genetic loci to US Hispanic womenM Graff, L Fernández-Rhodes, S Liu, et al.
BMJ (Clinical Research Ed.)|May 29, 2010
Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre studyClaire S Waddington, W T Walker, C Oeser, et al.
Breast Cancer Research and Treatment|November 15, 2014
Pathological non-response to chemotherapy in a neoadjuvant setting of breast cancer: an inter-institutional studyD Balmativola, C Marchiò, M Maule, et al.
European Journal of Cancer (Oxford, England : 1990)|September 7, 2000
Causes of inconsistency in diagnosing and classifying intraductal proliferations of the breast. European Commission Working Group on Breast Screening PathologyC W Elston, J P Sloane, I Amendoeira, et al.
Virchows Archiv : an International Journal of Pathology|January 29, 2016
Consistency in recognizing microinvasion in breast carcinomas is improved by immunohistochemistry for myoepithelial markersG Cserni, C A Wells, H Kaya, et al.
British Journal of Cancer|November 21, 2013
Relative survival of patients with non-malignant central nervous system tumours: a descriptive study by the Austrian Brain Tumour RegistryA Woehrer, M Hackl, T Waldhör, et al.
Pageof 36